RegCell
RegCell, Inc. is a biotechnology company developing first-in-class therapies for autoimmune diseases and transplantation using an epigenetic reprogramming platform based on regulatory T-cells (Tregs). Their platform aims to overcome limitations of current treatments by addressing multiple pathogenic antigens and offering a safer, scalable production method for cell therapies.
Buy Funded Startups lists
Funding Round: Seed
Funding Amount: $8.5M
Date: 18-Mar-2025
Investors: The University of Tokyo Edge Capital Partners (UTEC), Fast Track Initiative (FTI), Celadon Partners, Mitsubishi UFJ Capital, Osaka University Venture Capital (OUVC), Kyoto University Innovation Capital (Kyoto i-Cap)
Markets: Biotechnology, Cell Therapy, Immunology
HQ: Emeryville, California, United States
Founded: 2016
Website: http://www.regcellbio.com/
LinkedIn: https://www.linkedin.com/company/regcell
Crunchbase: https://www.crunchbase.com/organization/regcell
Leave a Comment
Comments
No comments yet.